From: Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
Age (mean)
50.8
Male
7
Female
32
Bethesda category
3 (AUS)
14
4 (FN)
21
5 (SUS)
4
RAS mutation
NRAS
20
HRAS
18
KRAS
1
Surgical management
Total thyroidectomy
5
Hemithyroidectomy
34